Yayın: Change in the ovarian environment after hysterectomy with bilateral salpingectomy: Is it the technique or surgery itself?
| dc.contributor.buuauthor | Atalay, Mehmet Aral | |
| dc.contributor.buuauthor | Demir, Bilge Çetinkaya | |
| dc.contributor.buuauthor | Özerkan, Kemal | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Kadın Hastalıkları ve Doğum Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0001-6897-3392 | |
| dc.contributor.researcherid | AAH-9834-2021 | |
| dc.contributor.researcherid | AAH-9791-2021 | |
| dc.contributor.scopusid | 53863297800 | |
| dc.contributor.scopusid | 36923039100 | |
| dc.contributor.scopusid | 6603345841 | |
| dc.date.accessioned | 2022-12-19T07:39:01Z | |
| dc.date.available | 2022-12-19T07:39:01Z | |
| dc.date.issued | 2016-07-20 | |
| dc.description.abstract | Objective: To compare the effects of total laparoscopic hysterectomy with bilateral salpingectomy (TLH-BS) and total abdominal hysterectomy with bilateral salpingectomy (TAH-BS) on ovarian function among women of reproductive age. Study design: One hundred and three patients with a diagnosis of benign uterine disorder were divided into two groups in this prospective longitudinal study. Patients who had never had sexual intercourse and patients with uterovaginal disproportion underwent TAH-BS (n = 57), and the remaining patients (n = 46) underwent TLH-BS. Ovarian function was assessed before and 6 months after surgery; ovarian volume was assessed by gray-scale ultrasonography, and levels of serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), oestradiol (E2), anti-Mullerian hormone (AMH) and inhibin B were measured. Results: Postoperative serum FSH, LH and inhibin B decreased significantly in both groups. Postoperative serum E2 did not change significantly. Postoperative serum AMH and ovarian volume decreased significantly in the TAH-BS group (p = 0.016 and p < 0.001, respectively), but not in the TLH-BS group. Significant differences were observed between the TLH-BS and TAH-BS groups with respect to change in FSH (p = 0.012) and ovarian volume (p = 0.001); between-group differences were not significant for changes in AMH and inhibin B. Conclusions: Although serum AMH did not change significantly in patients who underwent TLH-BS, ovarian aging commenced following both surgical procedures. | |
| dc.identifier.citation | Atalay, M. A. vd. (2016). "Change in the ovarian environment after hysterectomy with bilateral salpingectomy: Is it the technique or surgery itself?". European Journal of Obstetrics and Gynecology and Reproductive Biology, 204, 57-61. | |
| dc.identifier.doi | 10.1016/j.ejogrb.2016.07.483 | |
| dc.identifier.endpage | 61 | |
| dc.identifier.issn | 0301-2115 | |
| dc.identifier.issn | 1872-7654 | |
| dc.identifier.pubmed | 27522244 | |
| dc.identifier.scopus | 2-s2.0-84981306461 | |
| dc.identifier.startpage | 57 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ejogrb.2016.07.483 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0301211516308089 | |
| dc.identifier.uri | http://hdl.handle.net/11452/29949 | |
| dc.identifier.volume | 204 | |
| dc.identifier.wos | 000385321900011 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.bap | 2011-49 | |
| dc.relation.journal | European Journal of Obstetrics and Gynecology and Reproductive Biology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Obstetrics & gynecology | |
| dc.subject | Reproductive biology | |
| dc.subject | Abdominal hysterectomy | |
| dc.subject | Laparoscopic hysterectomy | |
| dc.subject | Salpingectomy | |
| dc.subject | Anti-mullerian hormone | |
| dc.subject | Ovarian function | |
| dc.subject | Anti-mullerian hormone | |
| dc.subject | Total abdominal hysterectomy | |
| dc.subject | Reserve | |
| dc.subject | Fsh | |
| dc.subject | Women | |
| dc.subject | Preservation | |
| dc.subject | Menopause | |
| dc.subject | Estradiol | |
| dc.subject | Inhibins | |
| dc.subject | Level | |
| dc.subject.emtree | Estradiol | |
| dc.subject.emtree | Follitropin | |
| dc.subject.emtree | Inhibin B | |
| dc.subject.emtree | Luteinizing hormone | |
| dc.subject.emtree | Muellerian inhibiting factor | |
| dc.subject.emtree | Estradiol | |
| dc.subject.emtree | Follitropin | |
| dc.subject.emtree | Inhibin | |
| dc.subject.emtree | Inhibin B | |
| dc.subject.emtree | Luteinizing hormone | |
| dc.subject.emtree | Muellerian inhibiting factor | |
| dc.subject.emtree | Abdominal hysterectomy | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | Benign uterus tumor | |
| dc.subject.emtree | Bilateral salpingectomy | |
| dc.subject.emtree | Estradiol blood level | |
| dc.subject.emtree | Female | |
| dc.subject.emtree | Follitropin blood level | |
| dc.subject.emtree | Gray scale echography | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Laparoscopic surgery | |
| dc.subject.emtree | Longitudinal study | |
| dc.subject.emtree | Luteinizing hormone blood level | |
| dc.subject.emtree | Major clinical study | |
| dc.subject.emtree | Outcome assessment | |
| dc.subject.emtree | Ovary function | |
| dc.subject.emtree | Postoperative period | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Prospective study | |
| dc.subject.emtree | Salpingectomy | |
| dc.subject.emtree | Sexual intercourse | |
| dc.subject.emtree | Uterus weight | |
| dc.subject.emtree | Blood | |
| dc.subject.emtree | Diagnostic imaging | |
| dc.subject.emtree | Hysterectomy | |
| dc.subject.emtree | Middle aged | |
| dc.subject.emtree | Organ size | |
| dc.subject.emtree | Ovary | |
| dc.subject.emtree | Physiology | |
| dc.subject.emtree | Uterus disease | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Anti-mullerian hormone | |
| dc.subject.mesh | Estradiol | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Follicle stimulating hormone | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Hysterectomy | |
| dc.subject.mesh | Inhibins | |
| dc.subject.mesh | Luteinizing hormone | |
| dc.subject.mesh | Middle aged | |
| dc.subject.mesh | Organ size | |
| dc.subject.mesh | Ovary | |
| dc.subject.mesh | Postoperative period | |
| dc.subject.mesh | Salpingectomy | |
| dc.subject.mesh | Uterine diseases | |
| dc.subject.scopus | Ovarian Neoplasms; Fallopian Tubes; Carcinoma In Situ | |
| dc.subject.wos | Obstetrics & gynecology | |
| dc.subject.wos | Reproductive biology | |
| dc.title | Change in the ovarian environment after hysterectomy with bilateral salpingectomy: Is it the technique or surgery itself? | |
| dc.type | Article | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı | |
| local.indexed.at | Scopus | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
